백혈구 성분채집술 시장 규모, 점유율, 성장 분석, 유형별, 용도별, 최종 사용자별, 지역별 - 산업별 예측(2024-2031년)

Global Leukapheresis Market size was valued at USD 66.3 million in 2022 and is poised to grow from USD 71.87 million in 2023 to USD 137.02 million by 2031, growing at a CAGR of 8.40% during the forecast period (2024-2031).

The global leukapheresis market is experiencing significant growth, driven by rising incidences of hematologic disorders and autoimmune diseases. This process of selectively separating white blood cells plays a crucial role in treating conditions like leukemia and autoimmune disorders while advancing diagnostic methods. Technological innovations in leukapheresis systems have improved procedure efficacy and safety, enhancing their appeal as a reliable therapeutic option. However, market growth could be hindered by limited awareness and high costs associated with the necessary equipment and trained personnel. Opportunities abound, especially in the intersection of leukapheresis and personalized medicine, as well as cell-based therapies like CAR T-cell treatment. As healthcare infrastructure develops, investment in research and cost-effective solutions could further expand this vital market sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Leukapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Leukapheresis Market Segmental Analysis

Global Leukapheresis Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into Disposables, Devices. Based on Application, the market is segmented into Research Applications, Therapeutic Applications. Based on End User, the market is segmented into Blood component providers & blood centers, Academic & research institutes, Pharmaceutical & biotechnology companies, Hospitals & transfusion centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Leukapheresis Market

The global leukapheresis market is primarily driven by the growing prevalence of hematologic disorders, including leukemia and lymphoma. As the incidence of these conditions continues to rise, the demand for effective treatment options becomes increasingly critical. Leukapheresis is instrumental in managing elevated white blood cell counts associated with these disorders, as it facilitates the rapid removal of leukemic cells from the bloodstream. This procedure not only alleviates symptoms but also helps in preparing patients for further therapeutic interventions. Consequently, the increasing recognition of leukapheresis as a vital treatment option significantly fuels market growth in this sector.

Restraints in the Global Leukapheresis Market

The global leukapheresis market faces several challenges that may impede its growth. A significant factor is the limited awareness of both healthcare providers and patients regarding the advantages of leukapheresis procedures. This lack of knowledge highlights the need for comprehensive educational initiatives aimed at fostering a better understanding of this therapeutic option. Additionally, the high expenses associated with leukapheresis devices and consumables pose another barrier, especially in resource-limited environments. Moreover, the requirement for skilled healthcare professionals to conduct these procedures further complicates accessibility, underscoring the necessity for targeted strategies to improve awareness and affordability in the market.

Market Trends of the Global Leukapheresis Market

The global leukapheresis market is witnessing a significant trend towards integration with cell-based therapies, particularly chimeric antigen receptor (CAR) T-cell therapy. This approach allows for the efficient collection and genetic modification of patient-derived white blood cells, which are essential for developing effective treatments against cancer. As healthcare providers increasingly recognize the potential of combining leukapheresis with advanced cell therapies, demand for leukapheresis technologies is expected to surge. This synergy not only enhances treatment efficacy but also drives innovation in leukapheresis procedures, positioning it as a cornerstone in the evolving landscape of personalized cancer care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Leukapheresis Market Size by Type & CAGR (2024-2031)

• Market Overview
• Disposables
• Devices
  • Centrifugal Devices
  • Membrane Separators

Global Leukapheresis Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
• Therapeutic Applications

Global Leukapheresis Market Size by End User & CAGR (2024-2031)

• Market Overview
• Blood component providers & blood centers
• Academic & research institutes
• Pharmaceutical & biotechnology companies
• Hospitals & transfusion centers

Global Leukapheresis Market Size & CAGR (2024-2031)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puriblood Medical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB-Kawasumi Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Discovery Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemExpress, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caltag Medsystems Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trina Bioreactives AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• First Choice Bio LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation